Cite
HARVARD Citation
Kulkarni‐Munje, A. et al. (2021). Disease‐duration based comparison of subsets of immune cells in SARS CoV‐2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity. Immunity, inflammation and disease. 9 (2), pp. 419-434. [Online].